4//SEC Filing
Charlton Ralph William III 4
Accession 0001415889-24-030001
CIK 0001683553other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:30 PM ET
Size
20.4 KB
Accession
0001415889-24-030001
Insider Transaction Report
Form 4
Charlton Ralph William III
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-12-16+31,750→ 172,668 total - Exercise/Conversion
Restricted Stock Units
2024-12-16−31,750→ 63,500 totalExercise: $0.00→ Common Stock (31,750 underlying) - Tax Payment
Common Stock
2024-12-10$0.54/sh−37,964$20,387→ 123,809 total - Tax Payment
Common Stock
2024-12-16$0.39/sh−9,491$3,689→ 140,918 total - Exercise/Conversion
Restricted Stock Units
2024-12-10−106,400→ 106,400 totalExercise: $0.00→ Common Stock (106,400 underlying) - Exercise/Conversion
Common Stock
2024-12-10+106,400→ 161,773 total - Tax Payment
Common Stock
2024-12-16$0.39/sh−11,329$4,404→ 161,339 total - Exercise/Conversion
Common Stock
2024-12-16+26,600→ 150,409 total - Exercise/Conversion
Restricted Stock Units
2024-12-16−26,600→ 79,800 totalExercise: $0.00→ Common Stock (26,600 underlying)
Footnotes (4)
- [F1]On December 14, 2023, the Reporting Person was granted a total of 212,800 RSUs. 50% or 106,400 of the total RSUs are performance-based and since certain specified performance goals were met, they all vested on December 10, 2024. An additional 106,400 of the total RSUs are time-based. 25% of which vested on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 26,600 shares vested and 9,491 shares were withheld for taxes, resulting in a net issuance of 17,109 shares.
- [F2]Each RSU represents a contingent right to receive one share of SPRB common stock.
- [F3]On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2024, 31,750 RSUs vested, with 11,329 shares being withheld for taxes, resulting in a net issuance of 20,421 shares.
- [F4]Represents the aggregate balance of time-based RSUs.
Documents
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
Related Parties
1- filerCIK 0001919397
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 8:30 PM ET
- Size
- 20.4 KB